Longevity Angitia Bio lands $130m to advance human trials of musculoskeletal health drugsBy adminFebruary 8, 20260 Company’s osteoporosis program completes enrollment in Phase 2 trial focused on treating the disease in postmenopausal women. US biotech Angitia…
